Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transcytosis of IgG01:15

Transcytosis of IgG

2.7K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.7K
Development of Immunocompetence01:22

Development of Immunocompetence

233
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
233
Physiological Barriers01:25

Physiological Barriers

3.2K
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transition from the m Phase to o Phase in an HZO Thin Film Revealed by In Situ TEM.

Nano letters·2026
Same author

Age-Associated Senescence of Decidual Macrophages: A Key Mediator of Adverse Pregnancy Outcomes in Advanced Maternal Age.

Aging cell·2026
Same author

4-Octyl itaconate attenuates renal calculi formation by inhibiting ferroptosis and oxidative stress via the Nrf2-HO-1/SLC7A11 axis.

European journal of pharmacology·2026
Same author

SIRT7-mediated ACSL3 delactylation suppresses colorectal cancer progression by orchestrating tumor-associated macrophage ferroptosis and polarization.

Cell death & disease·2026
Same author

Real-World Efficacy and Safety of Liposomal Amphotericin B for Invasive Fungal Disease in Patients with Hematologic Malignancies: A Multicenter Retrospective Study.

Drug design, development and therapy·2026
Same author

TIA1 depletion enhances CLSTN1 exon 11 inclusion to facilitate Epithelial-to-Mesenchymal transition and breast cancer metastasis.

Oncogene·2026

Related Experiment Video

Updated: May 8, 2025

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
07:51

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface

Published on: May 21, 2015

17.1K

Immune checkpoint for pregnancy.

Xiaohui Hu1, Siying Lai1, Aihua Liao2

  • 1Institute of Reproductive Health and Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Seminars in Immunopathology
|May 2, 2025
PubMed
Summary

Immune checkpoint molecules (ICMs) regulate maternal immune tolerance during pregnancy. Targeting these pathways offers potential therapeutic strategies for complicated pregnancies.

Keywords:
Immune checkpoint molecularImmune regulationImmunotherapyPregnancyPregnancy complications

More Related Videos

Isolation of Leukocytes from the Human Maternal-fetal Interface
08:19

Isolation of Leukocytes from the Human Maternal-fetal Interface

Published on: May 21, 2015

15.9K
Isolation of Uterine Innate Lymphoid Cells for Analysis by Flow Cytometry
09:02

Isolation of Uterine Innate Lymphoid Cells for Analysis by Flow Cytometry

Published on: October 14, 2021

4.5K

Related Experiment Videos

Last Updated: May 8, 2025

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
07:51

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface

Published on: May 21, 2015

17.1K
Isolation of Leukocytes from the Human Maternal-fetal Interface
08:19

Isolation of Leukocytes from the Human Maternal-fetal Interface

Published on: May 21, 2015

15.9K
Isolation of Uterine Innate Lymphoid Cells for Analysis by Flow Cytometry
09:02

Isolation of Uterine Innate Lymphoid Cells for Analysis by Flow Cytometry

Published on: October 14, 2021

4.5K

Area of Science:

  • Immunology
  • Reproductive Biology
  • Maternal-Fetal Medicine

Background:

  • Successful pregnancy requires maternal immune tolerance of the fetus.
  • Immune checkpoint molecules (ICMs) like PD-1, CTLA-4, and Tim-3 are crucial for immune regulation during gestation.
  • Dysregulation of ICMs is implicated in complicated pregnancies.

Purpose of the Study:

  • To review the expression and function of key ICMs at the maternal-fetal interface.
  • To explore the role of ICMs in maintaining immune tolerance during pregnancy.
  • To discuss the pathogenesis of complicated pregnancies involving immune checkpoints and their therapeutic potential.

Main Methods:

  • Review of current literature on immune checkpoint molecules in pregnancy.
  • Analysis of ICM expression patterns and functions at the maternal-fetal interface.
  • Examination of immune checkpoint pathways in complicated pregnancy pathogenesis.

Main Results:

  • ICMs are dynamically regulated at the maternal-fetal interface, crucial for immune tolerance.
  • Specific ICMs (PD-1, CTLA-4, Tim-3) play key roles in regulating maternal immune responses.
  • Alterations in ICM pathways are associated with the pathogenesis of complicated pregnancies.

Conclusions:

  • Understanding ICM regulation is vital for comprehending pregnancy immune dynamics.
  • Targeting ICMs presents a promising therapeutic avenue for managing complicated pregnancies.
  • Further research into ICMs may unveil novel clinical interventions for gestational complications.